Status:
COMPLETED
Comparison of Two Methods of Transnasal Sphenopalatine Ganglion Block
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Sphenopalatine Ganglion Block
Eligibility:
All Genders
20+ years
Brief Summary
The transnasal sphenopalatine ganglion block(SPGB) is administered to patients with facial or head and neck pain. In the transnasal approach, the drip and topical methods are frequently used. We compa...
Detailed Description
The objective of this study was to compare facial temperatures and visual analogue scale (VAS) between drip method and topical method of transnasal sphenopalatine ganglion block (SPGB). The transnasa...
Eligibility Criteria
Inclusion
- (1) age over 20 years ; (2) head and neck pain; (3) pain score \> 4 on the VAS in the head and neck; and (4) having undergone a transnasal SPGB and having had facial temperatures measured.
Exclusion
- (1) patients with a history of head and neck surgery, (2) treatment with a vasodilator or vasoconstrictor, (3) contraindication to treatment using a transnasal approach, (4) clinically significant systemic disease or any reduced organ failure, and (5) missing data.
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04479176
Start Date
March 10 2021
End Date
October 1 2021
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Suwon, Gyunggi, South Korea, 16499